Corneal degeneration is more common in white women

Article

Peripheral hypertrophic subepithelial corneal degeneration is an uncommon disorder that occurs mostly in white women with a distinct phenotype, claims a study in the journal Ophthalmology.

Peripheral hypertrophic subepithelial corneal degeneration is an uncommon disorder that occurs mostly in white women with a distinct phenotype, claims a study in the journal Ophthalmology.

The retrospective case series, led by Dr Daniel M. Gore, Moorfields Eye Hospital NHS Foundation Trust, London, UK, involved 22 patients under care of the External Disease Service at the hospital. The main outcome measures were clinical phenotype, symptoms, recurrence rate after surgery and histopathologic results.

Of the patients studied, 91% had peripheral and bilateral disorders and 41% had elevated circumferential peripheral subepithelial corneal opacities and adjacent abnormal limbal vasculature, with or without pseudopterygia. Seven patients from the latter group had bilateral disease.

The symptoms included ocular surface discomfort in 45% of patients, reduced vision in 18% of patients and both symptoms present in 23% of patients. It was discovered that 14% of patients were asymptomatic, 36% were administered topical lubricants, one patient required spectacles and 32% of patients underwent superficial keratectomy. The histopathologic changes were similar to those found in pterygia and Salzmann’s nodular degeneration.

Surgical excision was performed in 30% of the patients with infrequent short-term recurrences. The cause of peripheral hypertrophic subepithelial corneal degeneration is still unknown.

The paper can be viewed here.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
© 2025 MJH Life Sciences

All rights reserved.